Milton Pharmaceutical Company is experienced in the formulation development and is one of the few companies licensed for the clinical manufacture of live biotherapeutics being targeted for digestive, urogenital, otorhinologic and pulmonary delivery.
Understanding the client dosing requirements for the live biotherapeutic, Milton Pharmaceutical Company can prepare a formulation development strategy to bring it rapidly and effectively to First in Man (FIM) studies and on to further clinical use aiming to provide a formulation with the best chance of clinical outcome. Our formulation development and clinical services include:
Live Biotherapeutic Oral Dosage Forms:
- Immediate release and controlled release tablets
- Multilayer tablets
- Immediate release capsules
- Oral multiparticulates such as beads, pellets and mini-tablets
- Liquid and semi-solid filled capsules
- Fast dispersible tablets
- Coating of tablets, capsules and pellets
- Micro-encapsulation using spray drying
- Oral liquids and suspensions
Other Dosage Forms:
- Liquids and semi-solids for topical delivery, such as creams, ointments, lotions and gels
- Buccal delivery
- Nasal sprays
- Dental products
- Pessaries
- Suppositories